

Red Flags for Physicians Considering Paid Speaking Engagements
Recently, DOJ announced that pharmaceutical giant Pfizer, on behalf of its subsidiary, Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”), has agreed to pay nearly $60 million to resolve allegations that Biohaven knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to health care providers (“HCPs”) to induce prescriptions of Biohaven’s migraine drug Nurtec ODT before Pfizer acquired the company. The sett
Mar 27, 2025


Compensating Radiologists for Contrast Supervision
New revenue opportunities have opened up for radiology groups with CMS’ extension of flexibilities for the virtual supervision of radiology studies performed with contrast media. The extension allows facilities to provide Level 2 diagnostic tests, including CT and MRI scans, with a remotely located supervising provider through (at least) December 31, 2025. Before the COVID-19 epidemic in 2020, CT and MRI with contrast procedures had to be supervised by onsite physicians who w
Mar 24, 2025


Healthcare M&A Outlook - Trends, Opportunities, and Challenges
Looking ahead in 2025, the healthcare industry is set to experience a year filled with dynamic opportunities, particularly in mergers and...
Mar 10, 2025








